Brachytherapy
Volume 8, Issue 1 , Pages 63-69 , January 2009

Intraoperative seed placement for thoracic malignancy—A review of technique, indications, and published literature

  • Alexandra J. Stewart

      Affiliations

    • Department of Radiotherapy, Royal Surrey County Hospital, Guildford, England
    • Corresponding Author InformationCorresponding author. Consultant Clinical Oncology, St Luke's Cancer Centre, Royal Surrey County Hospital, Egerton Road, Guildford, GU2 7XX, England. Tel.: +44-1483-571122.
    • ,
  • Subhakar Mutyala

      Affiliations

    • Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Caroline L. Holloway

      Affiliations

    • BC Cancer Agency Centre for the Southern Interior, Kelowna, BC, Canada
    • ,
  • Yolonda L. Colson

      Affiliations

    • Division of Thoracic Surgery, Dana Farber, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
    • ,
  • Phillip M. Devlin

      Affiliations

    • Division of Brachytherapy, Department of Radiation Oncology, Dana Farber, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Received 22 July 2008 ,Revised 24 September 2008 ,Accepted 25 September 2008.

References 

  1. Hilaris BS, Martini N. Interstitial brachytherapy in cancer of the lung: a 20 year experience. Int J Radiat Oncol Biol Phys. 1979;5:1951–1956
  2. Hilaris BS, Dattatreyudu N, Beattie EJ, et al. Value of perioperative brachytherapy in the management of non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1983;9:1161–1166
  3. Hilaris BS, Gomez J, Nori D, et al. Combined surgery, intraoperative brachytherapy and postoperative external radiation in stage III non-small cell lung cancer. Cancer. 1985;55:1226–1231
  4. Armstrong JG, Fass DF, Bains M, et al. Paraspinal tumors: techniques and results of brachytherapy. Int J Radiat Oncol Biol Phys. 1991;20:787–790
  5. Fleischman EH, Kagan AR, Streeter OE, et al. Iodine 125 interstitial brachytherapy in the treatment of carcinoma of the lung. J Surg Oncol. 1992;49:25–28
  6. Aye RW, Mate TP, Anderson HN, et al. Extending the limits of lung cancer resection. Am J Surg. 1993;165:572–576
  7. Nori D, Li X, Pugkhem T. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: a pilot study. J Surg Oncol. 1995;60:257–261
  8. D'Amato TA, Galloway M, Szydlowski G, et al. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest. 1998;114:1112–1115
  9. Chen A, Galloway M, Landreneau R, et al. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys. 1999;44:1057–1063
  10. Rogers CL, Theodore N, Dickman CA, et al. Surgery and permanent 125I seed paraspinal brachytherapy for malignant tumors with spinal cord compression. Int J Radiat Oncol Biol Phys. 2002;54:505–513
  11. Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003;75:237–242
  12. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with stage I non small cell lung cancer. Surgery. 2003;134:691–697
  13. Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:261–267
  14. Voynov G, Heron DE, Lin CJ, et al. Intraoperative 125I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy. 2005;4:278–285
  15. Birdas TJ, Koehler RPM, Colonias A, et al. Sublobar resection with brachytherapy versus lobectomy for stage IB nonsmall cell lung cancer. Ann Thorac Surg. 2006;81:434–439
  16. Mutyala S, Khan AJ, Stewart AJ, et al. Outcomes of I-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2007;69:S751
  17. Heelan RT, Hilaris BS, Anderson LL, et al. Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning. Radiology. 1987;164:735–740
  18. You YN, Hunt KK, Posner MC, et al. Operative trials: the opportunity beckons—an update on the American College of Surgeons Oncology Group. Surgery. 2005;139:455–459
  19. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13 year analysis. Ann Thorac Surg. 2006;82:408–416
  20. Pisch J, Belsley SJ, Ashton R, et al. Placement of 125I implants with the da Vinci robotic system after video-assisted thoracoscopic wedge resection: a feasibility study. Int J Radiat Oncol Biol Phys. 2004;60:928–932
  21. Marchese MJ, Nori D, Anderson LL, et al. A versatile permanent planar implant technique utilizing iodine-125 seeds imbedded in gelfoam. Int J Radiat Oncol Biol Phys. 1984;10:747–751
  22. Thomadsen B, Ayyangar K, Anderson L, et al. Chapter 8: brachytherapy treatment planning. In:  Nag S editors. Principles and practice of brachytherapy. Armonk, NY: Future Publishing; 1997;p. 150–151
  23. Johnson M, Colonias A, Parda D, et al. Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer. Phys Med Biol. 2007;52:1237–1245
  24. Cormack RA, Holloway CL, O'Farrell D, et al. Permanent planar iodine-125 implants: the dosimetric effect of geometric parameters for idealized source configurations. Int J Radiat Oncol Biol Phys. 2007;69:1310–1315
  25. Stewart AJ, O'Farrell D, Mutyala S, et al. Case reports to describe toxicity resulting from permanent radioactive seed implantation for mediastinal carcinoid tumor. Brachytherapy. 2007;6:58–61
  26. Ricke J, Wust P, Wieners G, et al. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Chest. 2005;127:2237–2242
  27. Smith RP, Schuchert M, Komanduri K, et al. Dosimetric evaluation of radiation exposure during I-125 Vicryl mesh implants: implications for ACOSOG Z4032. Ann Surg Oncol. 2007;14:3610–3613
  28. Manchikanti L, Cash KA, Moss TL, et al. Risk of whole body radiation exposure and protective measures in fluoroscopically guided interventional techniques: a prospective evaluation. BMC Anesthesiol. 2003;3:2
  29. National Council on Radiation Protection. Limitation of exposure to ionizing radiation. NCRP Report No 116, Bethesda, MD 1993
  30. Hall EJ. Radiation protection. In:  Hall EJ,  Giaccia AJ editor. Radiobiology for the radiologist. 6 ed. Philadelphia: Lippincott, Williams and Wilkins; 2006;p. 224–239
  31. Smathers S, Wallner K, Korssjoen T, et al. Radiation safety parameters following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;45:397–399
  32. Michalski J, Mutic S, Eichling J, et al. Radiation exposure to family and household members after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;56:764–768

PII: S1538-4721(08)00643-0

doi: 10.1016/j.brachy.2008.09.002

Brachytherapy
Volume 8, Issue 1 , Pages 63-69 , January 2009

Article Tools

* Image Usage & Resolution